Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit

2021649 citationsJournal Articlebronze Open Access

Authors

ClinicalTrials.gov Identifier: NCT04486508.

Good health and well-being

Published in: JAMA

Volume 325, Issue 16, pp. 1620-1620

Field-Weighted Citation Impact: 40.44